Leadership
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
In this page, AHRMM recommends these 3 proactive activities in the event of economic downturn.
View a copy of the survey report (PDF)
This Special Fraud Alert focuses on the specific attributes and practices of PODs that OIG believes produce substantial fraud and abuse risk and pose dangers to patient safety.
On November 21, 2013, AHRMM submitted electronically
As a membership organization, AHRMM is strengthened by the volunteers and leaders that shape the future of the Association. These leaders have positioned themselves at the forefront of the entire health care supply chain field. Here’s everything you need to know about AHRMM leadership: